BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2012
View Archived Issues
MS-275 as a potential therapy for NASH
Read More
Veloxis reports preliminary results from STRATO study
Read More
Omeros advances lead PDE10 program candidate study
Read More
Scancell reports data from first part of phase I/II SCIB-1 trial
Read More
DNDi launches pivotal trial of oral drug candidate for African sleeping sickness
Read More
Board recommends continuation of phase III ReLive trial
Read More
Clinical results reported for OC-000450 in grass pollen allergy
Read More
Intradermal injection of HDM-PAD safe and well tolerated in subjects with HDM allergies
Read More
Chinese scientists present new histone deacetylase inhibitors
Read More
Novel M4 receptor modulators patented by The Vanderbilt University
Read More
Scientists at Nerviano Medical Sciences patent new protein kinase inhibitors
Read More
Array BioPharma divulges new protein kinase pim inhibitors
Read More
Gedeon Richter synthesizes novel MCH1 receptor antagonists
Read More
Inovio Pharmaceuticals reports data from trial of its electroporation vaccine delivery system
Read More
Abbott designs new GlyT-1 inhibitors
Read More
Roche submits line extension application to the EMA for MabThera
Read More
Novel TLR4 antagonist demonstrates protective effects in NAFLD
Read More
University of Texas MD Anderson and GSK to collaborate on therapeutic antibodies against cancer
Read More
FDA advisory committee votes on approval of Zohydro ER
Read More
Protalix initiates study of long-term enzyme replacement therapy for Fabry's disease
Read More
Isis Pharmaceuticals reports phase I data for three drugs
Read More
First patients treated in phase II study of EMA-401
Read More
Eleven Biotherapeutics begins phase Ib study in dry eye disease
Read More
HM1.24-specific humanized MAb combined with lenalidomide in MM
Read More
Clinical studies presented for circularly permuted TRAIL in MM
Read More
Biogen Idec and Isis Pharmaceuticals enter global antisense drug collaboration
Read More
Tudorza Pressair now available in the U.S.
Read More
Pfizer presents phase II data for PD-0332991 plus letrozole
Read More